The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
about
Apolipoprotein A-I and CancerAnimal models and the tumor microenvironment: studies of tumor-host symbiosisHigh-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung DiseaseAIBP: A Novel Molecule at the Interface of Cholesterol Transport, Angiogenesis, and AtherosclerosisHDL as a drug and nucleic acid delivery vehicleHigh-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation Cohort.Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression.Ginsenoside-Rp1-induced apolipoprotein A-1 expression in the LoVo human colon cancer cell line.The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity.Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory propertiesPotential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.Variants of SCARB1 and VDR Involved in Complex Genetic Interactions May Be Implicated in the Genetic Susceptibility to Clear Cell Renal Cell CarcinomaEfficacy of tomato concentrates in mouse models of dyslipidemia and cancer.Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer risk.Synthetic high-density lipoprotein-like nanoparticles for cancer therapyEffect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancerIdentification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein InteractionApolipoprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome: A case-control studySerum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.Pyranocoumarin Tissue Distribution, Plasma Metabolome and Prostate Transcriptome Impacts of Sub-Chronic Exposure to Korean Angelica Supplement in MiceHigh level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma.Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometryDiagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometryAcute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivoApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer.An abundant dysfunctional apolipoprotein A1 in human atheroma.Serum Apo A-1 and Its Role as a Biomarker of Coronary Artery Disease.Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases.Impact of Serum Apolipoprotein A-I on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer: a Propensity Score-Matched Analysis.Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection.The role of high-density lipoproteins in the regulation of angiogenesis.Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-Protein Interaction Networks.Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.Apolipoprotein A-I: A Molecule of Diverse Function.Combining LDL-C and HDL-C to predict survival in late life: The InChianti study.Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancerMolecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases.Scavenger Receptor Type B1 and Lipoprotein Nanoparticle Inhibit Myeloid Derived Suppressor Cells.High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation.HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
P2860
Q26776188-EEBF4290-F929-43CD-B33C-2CB1E3F74791Q26853538-99CD4B54-E39E-417B-A623-1DB5E2D97E66Q28075541-4B576CD8-1928-4378-9E35-411EBBC8F9ADQ28083058-DEEF8188-3329-47A5-AB1D-793652B56F05Q28083209-4F29729E-08CC-4414-83D3-531D5BA8508EQ31127155-9779AC0B-339E-4120-94A9-B4292DA0AD93Q33779353-419CF805-27A9-413D-B5C5-BCC1C9F25F65Q34424772-4A6F5921-982B-41C9-99D5-40FFA36E361FQ35141775-68D3D7E4-ED5D-4D58-B853-256513323BB3Q35303738-25FAC15B-50EC-4755-B938-21C11021BFD7Q35452689-CA01404A-262D-49AC-B0E1-ED3155549310Q35475660-18A17683-0A25-427F-B975-5824C84AA7C6Q35822272-764B60B1-D8A7-4D4D-A211-6254770E7DFAQ36252985-82443193-1B56-40F1-822D-CF5023F2FAA6Q36264073-3CEDC54B-1377-4FDB-9E57-38857E0D5DDFQ36281632-1EF5B909-6C78-4141-B7D2-2202A5DFBA7EQ36489313-324DBF4F-EFDD-4873-8D95-809BCFD00588Q36584287-7B2034DD-D55C-47C8-9CF4-F174CE7874C5Q36685565-0CCFCE02-99B4-49E9-AF34-30F533C899FAQ36915328-3E370FE6-E3D4-401B-890D-82822FC98A75Q37118144-7DE737BD-CC07-484C-8185-8DB519C1E404Q37174708-44EAFDE6-2867-4558-A881-5E922EF067F6Q37187745-827D66D0-F933-497F-87FF-51998A7EC92FQ37270341-1DAEE59C-54A5-4A4F-ABB3-A1C065964D7EQ37390177-46026794-E05B-42CD-9779-534DAB4C71F8Q37581580-7D4C3FDC-FED0-4FD0-BB90-795829392279Q37603797-25967AB9-D541-45AC-8E58-2EF1C12EAC0FQ37636796-44291BB2-D54D-45F2-BD7A-259D50706C5DQ37678218-D036B875-E1FB-4A72-9C5E-D542E815C498Q37688597-ABCC35ED-50E6-4BFB-B605-9211B47C0243Q38373133-7A085C84-6F6A-4F6D-88AE-65922D586BD1Q38436698-FCBBC3DA-DDE1-47EA-911E-3DE7430A107BQ38807248-446C1CBB-8A0F-4392-A204-584BD6CEA8D3Q38844884-F36AF8B7-E9CA-46CE-A099-867F3273E69DQ42366212-7E4F2668-11C0-415F-BF85-E1B497A9B201Q42700846-9BF786BE-CAEE-41EF-B41F-F01B4182E10AQ46006378-33E76B77-BF1A-4D28-B3E4-D62228282608Q47241403-C4101DC1-078C-4D86-8B25-9E75D3A0B620Q48113241-79F4D1AD-8567-4018-BCF1-1A793ADE4E7BQ49548633-83172EAD-4DA3-4770-B920-B18565105199
P2860
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
@ast
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
@en
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
@nl
type
label
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
@ast
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
@en
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
@nl
prefLabel
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
@ast
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
@en
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
@nl
P2093
P2860
P50
P3181
P356
P1476
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects
@en
P2093
Daniel Lindner
Denise Hatala
Elizabeth Klipfell
Jennifer Buffa
Joseph A DiDonato
Maryam Zamanian-Daryoush
Mohamed Sharif S Yusufishaq
Pat Rayman
Patricia Parsons-Wingerter
P2860
P304
P3181
P356
10.1074/JBC.M113.468967
P407
P577
2013-07-19T00:00:00Z